Donald Bunjes
Stem Cell Transplantation Programme
Department of Haematology/Oncology
Ulm University Hospital
Robert-Koch-Strasse 8
Germany
Name/email consistency: high
- 188Re-labeled anti-CD66 monoclonal antibody in stem cell transplantation for patients with high-risk acute myeloid leukemia. Bunjes, D. Leuk. Lymphoma (2002)
- Rhenium 188-labeled anti-CD66 (a, b, c, e) monoclonal antibody to intensify the conditioning regimen prior to stem cell transplantation for patients with high-risk acute myeloid leukemia or myelodysplastic syndrome: results of a phase I-II study. Bunjes, D., Buchmann, I., Duncker, C., Seitz, U., Kotzerke, J., Wiesneth, M., Dohr, D., Stefanic, M., Buck, A., Harsdorf, S.V., Glatting, G., Grimminger, W., Karakas, T., Munzert, G., Döhner, H., Bergmann, L., Reske, S.N. Blood (2001)
- T cell depletion of allogeneic stem cell grafts with anti-CD 52 monoclonal antibodies: the Ulm experience from 1983-1999. Bunjes, D. Transfus. Sci (2000)









